[ACRV] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
11-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -25.14%
YoY- -143.46%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 CAGR
Revenue 0 0 0 -
PBT -18,798 -13,914 -5,820 79.57%
Tax 0 7 -105 -
NP -18,798 -13,914 -5,715 81.21%
Tax Rate - - - -
Total Cost 18,798 13,914 5,715 81.21%
Ratio Analysis
30/06/24 30/06/23 30/06/22 CAGR
NP Margin 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 CAGR
EPS -0.52 -0.63 -0.44 8.69%
EPS Diluted -0.52 -0.63 -0.44 8.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.